“Prolia has consistently been proven to increase bone density based on clinical trials conducted over 10 years. Patients prescribed with Prolia have demonstrated such. Based on this evidence we hope that Prolia’s preventative effect on bone fracture becomes known in South Korea.“

During a recent meeting with Daily Pharm, David Dempster, (Hons) Professor at Columbia University in the U.S., assessed the osteoporosis treatment, Prolia (denosumab), as such.

Osteoporosis is a chronic disease that weakens bones due to lowered bone density, and it cannot be completely recovered. After the diagnosis of osteoporosis, inadequate treatment may lead to a bone fracture with a minor fall in daily li